Pathophysiological role of leptin in obesity-related hypertension

Journal of Clinical Investigation

Volumn 105, Issue 9, 2000, Pages 1243-1252

  Aizawa Abe, Megumi ^a   Ogawa, Yoshihiro ^a   Masuzaki, Hiroaki ^a   Ebihara, Ken ^a   Satoh, Noriko ^a   Iwai, Hidenori ^a   Matsuoka, Naoki ^a   Hayashi, Tatsuya ^a   Hosoda, Kiminori ^a   Inoue, Gen ^a   Yoshimasa, Yasunao ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CATECHOLAMINE; HORMONE ANTAGONIST; LEPTIN;

ADOLESCENT; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CALORIC RESTRICTION; CATECHOLAMINE EXCRETION; CONTROLLED STUDY; FOOD INTAKE; GANGLION BLOCK; HYPERTENSION; MALE; MOUSE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE;

EID: 12944257370     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8341     Document Type: Article

References (61)

1. Kannel, W.B., Brand, M., Skinner, Jr., J.J., Sawber, T.R., and McNamara, P.M. 1967. The relation of adiposity to blood pressure and development of hypertension the Framingham study. Ann. Intern. Med. 67:48-59.
2. Reaven, G.M. 1988. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
3. Landsberg, L., and Krieger, D.R. 1989. Obesity, metabolism, and the sympathetic nervous system. Am. J. Hypertension. 2:125S-132S.
4. Mark, A.L., Correia, M., Morgan, D.A., Shaffer, R.A., and Haynes, W.G. 1999. Hypertension 33:537-541.
5. Rocchini, A.P., et al. 1989. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N. Engl. J. Med. 31:580-585.
6. Overton, J.M., VanNess, J.M., and Casto, R.M. 1996. Food restriction reduces sympathetic support of blood pressure in spontaneously hypertensive rats. J. Nutri. 127:655-660.
7. Kushiro, T., et al. 1991. Role of sympathetic activity in blood pressure reduction with low calorie regimen. Hypertension. 17:965-968.
8. Ikeda, T., Gomi, T., Hirawa, N., Sakurai, J., and Yoshikawa, N. 1996. Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. Hypertension. 27:1180-1186.
9. Spiegelman, B.M., and Flier, J.S. 1996. Adipogenesis and obesity: rounding out the big picture. Cell. 87:377-389.
10. Zhang, Y., et al. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425-432.
11. Collins, S., et al. 1996. Role of leprin in fat regulation. Nature. 380:677.
12. Haynes, W.G., Morgan, D.A., Walsh, S.A., Mark, A.L., and Sivitz, W.I. 1997. Receptor-mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 100:270-278.
13. Dunbar, J.C., Hu Y., and Lu, H. 1997. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 46:2040-2043.
14. Searpace, P.J., Matheny, M., Pollock, B.H., and Tumer, N. 1997. Leptin increases uncoupling protein expression and energy expenditure. Am. J. Physiol. 273:E226-E230.
15. Satoh, N., et al. 1999. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes. 48:1787-1793.
16. Tartaglia, L.A , et al. 1995. Identification and expression cloning of a leptin receptor. OB-R. Cell. 83:1263-1271.
17. Takaya, K., et al. 1996. Molecular cloning of rat leptin receptor isoform complementary DNAs: identification of a missense mutation in Zucker fatty (fa fa) rats. Biochem. Biophys. Res. Commun. 225:75-83.
18. Schwartz, M.W., Seeley, R.J., Campfield, L.A., Burn, P., and Baskin, D.G. 1996. Identification of target of leptin action in rat hypothalamus. J. Clin. Invest. 98:1101-1106.
19. Fei, H., et al. 1997. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc. Natl. Acad. Sci. USA. 94:7001-7005.
20. Satoh, N., et al. 1997. The arcuate nucleus is a primary site of satiety effect of leptin in rats. Neurosci. Lett. 224:149-152.
21. Elmquist, J.K., Maratos-Flier, E., Saper, C.B., and Flier, J.S. 1998. Unraveling the central nervous system pathway underlying responses to leptin. Nat. Neurosci. 1:445-450.
22. Seeley, R.J., et al. 1997. Melanocortin receptors in leptin effects. Nature. 390-349.
23. Satoh, N., et al. 1998. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci. Lett 249:107-110.
24. Frederich, R.C., et al. 1995. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat. Med. 1:1311-1314.
25. Maffei, M., et al. 1995. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1:1155-1161.
26. Considine, R.V., et al. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:292-295.
27. Agata, J., et al. 1997. High plasma immunoreactive leptin level in essential hypertension. Am. J. Hypertension. 10:1171-1174.
28. Ogawa, Y., et al. 1999. Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes. 48:1822-1829.
29. Masuzaki, H., et al. 1999. Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes. 48:1615-1622.
30. Bultman, S.J., Michaud, E.J., and Woychik, R.P. 1992. Molecular characterization of the mouse agouti locus. Cell. 71:1195-1204.
31. Miller, M.W., et al. 1993. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev. 7:454-467.
32. Halaas, J.L., et al. 1997. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. USA. 94:8878-8883.
33. Lu, D., et al. 1994. Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature. 371:799-802.
34. Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J., and Cone, R.D. 1997. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:165-168.
35. Iwatsuka, H., Shino, A., and Suzuoki, Z. 1970. General survey of diabetic features of yellow KK mice. Endocrinol. Jpn. 17:23-35.
36. Kondo, K., Nozawa, K., Tomita, T., and Ezaki, K. 1957. Inbred strains resulting from Japanese mice. Bull. Exp. Anim. 6:107-116.
37. Ogawa, Y., et al. 1994. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J. Clin. Invest. 93:1911-1921.
38. Leigh, F.S.M., Kaufman, L.N., and Young, J.B. 1992. Diminished epinephrine excretion in genetically obese (ob/ob) mice and monosodium glutamate-treated rats. Int. J. Obes. 16:597-604.
39. Shek, E.W., Brands, M.W., and Hall, J.E. 1998. Chronic leptin infusion increases arterial pressure. Hypertension. 31:409-414.
40. Casto, R.M., VanNess, J.M., and Overton, J.M. 1998. Effects of central leptin administration on blood pressure in normotensive rats. Neurosci. Lett. 246:29-32.
41. Lu, H., et al. 1998. Obesity due to high fat diet decreases the sympathetic nervous and cardiovascular responses to intracerebroventricular leptin in rats. Brain Res. Bull. 47:331-335.
42. Sierra-Honigmann, M.R., et al. 1998. Biological action of leprin as an angiogenic factor. Science. 281:1683-1686.
43. Bouloumie, A., Drexler, H.C.A., Lafontan, M., and Busse, R. 1998. Leptin, the product of ob gene, promotes angiogenesis. Cric. Res. 83:1059-1066.
44. Cao, G.Y., Considine, R.V., and Lynn, R.B. 1997. Leptin receptor in the adrenal medulla of the rat. Am. J. Physiol. 273:E448-E452.
45. Dunbar, J.C., and Lu, H. 1999. Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products. Brain Res. Bull. 50:215-221.
46. Haynes, W.G., Morgan, D.A., Djalali, A., Sivitz, W.I., and Mark, A.L. 1999. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension. 33:542-547.
47. VanNess, J.M., DeMaria, J.E., and Overton, J.M. 1999. Increased NPY activity in the PVN contributes to food-restriction induced reductions in blood pressure in aortic coarctation hypertensive rats. Brain Res. 821:263-269.
48. Morton, K.D.R, McCloskey, M.J.D., and Potter, E.K. 1999. Cardiorespiratory responses to intracerebroventricular injection of neuropeptide Y in anaesthetised dogs. Regul. Peptides. 81:81-88.
49. Stephens, T.W., et al. 1995. The role of neuripeptide Y in the antiobesity action of the obese gene product. Nature. 377:530-532.
50. Herberg, L., and Coleman, D.L. 1977. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism. 26:59-87.
51. Leibel, R.L., Chung, W.K., and Chua, S.C. 1997. The molecular genetics of rodent single gene obesities. J. Biol. Chem. 272:31937-31940.
52. Huszar, D., et al. 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:131-141.
53. Segal, K.R., Landt, M., and Klein, S. 1996. Relationship between insulin sensitivity and plasma leptin concentrations in lean and obese men. Diabetes. 45:988-991.
54. Saladin, R., et al. 1995. Transient increase in obese gene expression after fond intake or insulin administration. Nature. 377:527-529.
55. Ahima, R.S., et al. 1996. Role of leptin in the neuroendocrine response to fasting. Nature. 382:250-252.
56. Lord, G.M., et al. 1998. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 394:897-901.
57. Takaya, K., et al. 1996. Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat. Genet. 14:130-131.
58. Phillips, M.S., et al. 1996. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet. 13:18-19.
59. Kurtz, T.W., Morris, R.C., and Pershadsingh, H.A. 1989. The Zucker fatty rat as a generic model of obesity and hypertension. Hypertension. 13:896-901.
60. Farooqi, I.S., et al. 1999. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341:879-884.
61. Heymsfield, S.B., et al. 1999. Recombinant leptin for weight loss in obese and lean adults: a randomised, controlled, dose-escalation trial. JAMA. 282:1568-1575.